Imunon, Inc.·4

May 27, 4:13 PM ET

Pellizzari Christine A 4

4 · Imunon, Inc. · Filed May 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Imunon (IMNN) Director Christine Pellizzari Receives 5,557 Shares

What Happened
Christine A. Pellizzari, a director of Imunon, Inc. (IMNN), was granted 5,557 shares of common stock on May 22, 2026. The grant value is recorded at $2.20 per share, totaling $12,225. This transaction is an award/grant (code A) — shares issued in lieu of cash compensation for board fees, not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-05-22; filing date: 2026-05-27 (filed within the SEC two-business-day window).
  • Price per share reported: $2.20; total value: $12,225.
  • Transaction type/code: Award/Grant (A). Footnote F1: stock granted in lieu of cash for a portion of board fees.
  • Post-transaction total shares held by the reporting person: not disclosed in the provided filing excerpt.
  • Additional remark: On August 21, 2025 the company paid a 15% stock dividend (0.15 shares per share), and the Issuer adjusted reported share amounts accordingly.

Context: Awards issued in lieu of cash compensation are a routine form of director compensation and do not necessarily indicate the director buying or selling shares based on a view of the company. The filing appears timely and informational for shareholders tracking insider compensation and dilution.

Insider Transaction Report

Form 4
Period: 2026-05-22
Transactions
  • Award

    Common Stock

    [F1]
    2026-05-22$2.20/sh+5,557$12,2258,142 total
Footnotes (1)
  • [F1]Stock granted in lieu of cash for portion of board fees
Signature
/s/ Susan Eylward, Attorney-in-Fact for Christine Pellizzari|2026-05-27

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4